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Objective: Determining renal resistive index (RI) in the setting of renal artery stenosis may predict which patients benefit
from revascularization. Renal duplex ultrasonography (RDUS) is the traditional method of assessing RI, but it is not
available in most invasive endovascular laboratories. Conversely, endovascular techniques to assess RI are available but
not well validated. The primary goal was to determine if an invasive approach using an endovascular Doppler flow wire
correlates with RI assessment using traditional noninvasive RDUS.
Methods: In a single-center prospective trial, patients were enrolled if they had known or suspected renovascular disease.
A Doppler flow wire was placed in multiple segments of the renal artery, and peak (PSV) and end-diastolic velocities
(EDV)weremeasured. RI was calculated using the formula: RI [1 – (EDV/PSV)] 100. Similarly, RI was also derived
using standard RDUS. All patients underwent both RI techniques before any revascularization procedure. Secondary end
points included assessing the correlation for pole-to-pole renal length assessment and PSV and EDV velocities using both
invasive and noninvasive techniques. Pearson correlation coefficient calculations were used to determine degree of
correlation.
Results: The study enrolled 20 patients, and 35 renal arteries were studied. Overall, Pearson correlation coefficient for
invasive vs noninvasive RI assessment was 0.86 (95% confidence interval [CI], 0.73 to 0.93). The r values were 0.43 (95%
CI, 0.11 to 0.67) for pole-to-pole renal length, 0.66 (95% CI, 0.54 to 0.76) for PSV, and 0.61 (95% CI, 0.48 to 0.72)
for EDV determination. No major complications occurred during this study. Average time to perform invasive Doppler
assessment was 10.4  7.4 minutes per artery.
Conclusions: Invasive RI assessment using an endovascular flow wire technique correlates well with traditional noninva-
sive RDUS. A moderate statistical correlation also exists for pole-to-pole renal length, PSV, and EDV determinations.
The procedure is safe and can be performed rapidly. ( J Vasc Surg 2007;45:284-8.)Renal artery stenosis (RAS) is a complex clinical entity
leading to a variety of clinical presentations, ranging from
asymptomatic to combinations of hypertension, renal in-
sufficiency, and volume disturbance syndromes such as
flash pulmonary edema. RAS has been identified as an
important and often reversible cause of secondary hyper-
tension or renal failure, or both.1,2
Many clinicians presently use screening renal angiogra-
phy as an adjunct to coronary or peripheral angiography.
This practice often leads to renal artery revascularization
based on degree of stenosis alone, irrespective of the clinical
context. Although there is no clear consensus about the
degree of renal artery narrowing that justifies revasculariza-
tion, interventionalists generally define the minimal thresh-
old for an angiographically significant artery stenosis to be a
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28450% luminal diameter reduction.3,4 Even this is acknowl-
edged as only an approximate guide to the hemodynamic
effect of the stenosis.
Renal resistive index (RI) is a dimensionless index that
assesses the degree of renal microvascular disease. Existing
data suggest the RI is an important predictor of clinical
benefit after renal revascularization and is considered a key
element of RAS evaluation before invasive treatment.5,6
The current standard technique used to derive the RI is
noninvasive renal duplex ultrasonography (RDUS). Unfor-
tunately, this test is not immediately available in most busy
endovascular laboratories. The primary goal of the Renal
Artery Stenosis Invasive Doppler (RAIDER) study is to
correlate invasive measurements of RI using endovascular
Doppler flow wire techniques with noninvasive, RDUS-
derived measurements.
MATERIALS AND METHODS
Patient selection. Approval for this study was ob-
tained from the Institutional Review Board of the partici-
pating hospital. Patients were enrolled after giving in-
formed consent if they met study inclusion criteria.
Included were patients referred for coronary or peripheral
angiography who had suspected (hypertension resistant to
n RI
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disease. RAS was identified as arterial diameter narrowing
50% on angiography by visual estimate. Exclusion criteria
included acute ST-segment elevation myocardial infarc-
tion, cardiogenic shock, or total occlusion of the renal
artery precluding the use of a translesional guidewire, or
other clinical or anatomic criteria that were considered too
high-risk as determined by the senior physician operator.
Pregnant women were also excluded. Only patients who
underwent both invasive Doppler flow wire and RDUS
assessments before any renal revascularization were in-
cluded in the final analysis.
Renal angiography. Selective renal angiography was
performed on all visualized renal arteries with an appropri-
ately selected diagnostic catheter and hand injection of
contrast. Angiography was performed with digital subtrac-
tion techniques when available. Quantitative angiography,
stenosis assessment, and contrast-enhanced pole-to-pole
renal length measurements were also performed. Specifi-
cally, stenosis severity was based on smallest vessel diameter
using electronic calipers divided by the largest diameter in a
normal-appearing segment of the main renal artery.
Invasive Doppler measurements. Doppler measure-
ments were performed using a 0.014-inch Doppler-tipped
Flowire (Volcano Therapuetics, Rancho Cordova, Calif)
with concurrent heparin administration to maintain ade-
quate anticoagulation. The device was advanced into the
renal artery through the diagnostic catheter. The external
tip of the Doppler wire was connected to a ComboMap
pressure and flow system (Volcano Therapeutics). Doppler
spectral forms were optimized by slowly rotating the J-
shaped wire and monitoring both the image screen and the
auditory Doppler signal (Fig 1).
Peak systolic velocities (PSV, cm/s) and end-diastolic
velocities (EDV, cm/s) were recorded in the proximal,
middle, and distal renal artery and also at a first-order
segmental branch. RI values were calculated using the
equation: RI [1 (EDV/PSV)] 100. The reported RI
was an average of two to four measurements obtained in
these arterial segments.
Renal duplex ultrasonography. All patients under-
Fig 1. Example of invasive Doppler flow wire velocity w
80 cm/s. End-diastolic velocity is 15 cm/s. This yields awent bilateral RDUS in the noninvasive vascular labora-tory, where velocities, pole-to-pole renal lengths, and RI
values were recorded. These data were all obtained before
any revascularization procedure. RDUS was performed in
the usual protocol at our local noninvasive vascular labora-
tory, which is certified by the Intersocietal Commission for
the Accreditation of Vascular Laboratories. Standard diag-
nostic equipment included Philips-ATL HDI 3000 ultra-
sound system (Bothell, Wash) with a 5.0-MHz to 2.0-
MHz curved linear array probe or a 4.0-MHz to 2.0-MHz
broadband phased array probe.
Statistical analysis. The primary study end point was
the correlation between RI values determined by the inva-
sive Doppler flow wire and noninvasive RDUS techniques
using the Pearson correlation coefficient. Secondary end
points included correlations of pole-to-pole renal length
and renal arterial PSV and EDV. Also examined were time
to perform invasive RI assessment, defined as the timewhen
the Doppler wire was introduced into the renal artery to the
time it was removed, and safety, including dissection, throm-
bosis, acute renal failure, and in-hospital dialysis.
Scatter plots of RI measurements, pole-to-pole renal
length, PSV, and EDV determination were generated, and
calculations were performed of the Pearson correlation, as
well the Spearman correlation and the C-index coefficient
with 95% confidence intervals (CI), by using the Fisher z
transformation and bootstrapping. Neither the Pearson
correlation nor the Spearman and C-index can detect scale
or shift changes. Central tendency and scale of the two
measurements were also compared by calculating means
(using a paired t test) and comparing variances. Finally, we
used linear mixed-effects models that regressed noninvasive
and invasive velocity measurements that contained a ran-
dom intercept for subjects. This was done to account for
possible interdependence of measurements within subjects.
RESULTS
Between March 2005 and April 2006, 20 participants
were enrolled and 35 renal arteries were studied. Table I
summarizes the baseline patient characteristics. Average
patient age was 67.2  20 years, with a baseline serum
creatinine of 1.31  0.48 mg/dL, and calculated glomer-
rms in the mid renal artery. Peak systolic velocity here is
of 81.avefoular filtration rate of 57.6  24.1 mL/min. RAS was
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stenosis severity of 74.4%  14.0%. All 20 attempted en-
dovascular assessments of patients with RI were successful.
The study results are summarized in Table II. The mean
right renal artery RI by invasive Doppler was 78 20, with a
corresponding right RI by RDUS of 78 21. This yielded a
right renal artery Pearson’s coefficient value of 0.92. The
mean left renal artery RI by invasive Doppler was 82  21,
with a corresponding left RI by RDUS of 81 20, providing
left renal system Pearson’s coefficient value of 0.79. The
overall r value comparing the two RI techniques was 0.86
(95% CI, 0.73 to 0.93). The results were then reanalyzed
using linear mixed-effects models, as stated in our statistical
methods. The results of these mixed effects models did not
differ substantially from the one we report.
The mean right pole-to-pole renal length by angiogra-
phy was 10.4  3.1 cm, with a corresponding right pole-
to-pole renal length by RDUS of 10.6 2.7 cm (r 0.44).
The left pole-to-pole renal length by angiography was
10.9  32.9 cm, with a corresponding left pole-to-pole
renal length by RDUS 11.0  2.8 cm (r  0.37). The
overall r value comparing the two techniques to assess
pole-to-pole renal length was 0.43 (95% CI, 0.11 to 0.67).
PSV in the right renal arteries averaged 147  110
cm/s by Doppler wire and 234  130 cm/s by RDUS. In
the left renal arteries, average PSV was 127 102 cm/s by
Doppler flow wire and 185  110 cm/s by RDUS. The
overall Pearson’s coefficient value using a variance-stabilizing
transformation was 0.66 (95% CI, 0.54 to 0.76). EDV in the
right renal arteries average 18.5 23.9 cm/s byDoppler wire
and 28.5  38.7 cm/s by RDUS. Average EDV in the left
was 13.3  12.3 cm/s by Doppler wire and 19.3  18.9
cm/s by RDUS. The overall Pearson’s coefficient value was
0.61 (95% CI, 0.48 to 0.72). The average time to perform
an invasive RI assessment per renal artery was 10.9  7.6
minutes. No major complications were noted during this
study, including any episodes of vascular injury, thrombo-
Table I. Patient baseline characteristics
Characteristic Value n  20 (%)*
Renal arteries studied 35
Age 67.2  20
Males 11 (55)
Baseline LVEF (%) 56.7  18
Hypertension 16 (80)
Diabetes 9 (45)
PVD (not including RAS) 8 (40)
Antihypertensive agents (n) 2.7  1.5
Serum creatinine (mg/dL) 1.31  0.48
GFR† (mL/min) 57.6  24
Average RAS diameter (%) 74.4  14
LVEF,Left ventricular ejection fraction; PVD, peripheral vascular disease,GFR,
glomerular filtration rate; RAS, renal artery stenosis.
*Data based on enrollment of 20 patients. N (%) listed for categoric
variables; mean  standard deviation listed for continuous variables where
appropriate.
†Based upon modification of diet in renal disease equation.sis, acute renal failure, in-hospital dialysis, or death.DISCUSSION
RAS is frequently identified by angiography before
noninvasive physiologic assessment. This has become more
common as a result of aggressive screening efforts among
patients undergoing coronary and peripheral vascular pro-
cedures.2,7 An emerging dilemma from this practice is the
inability to adequately assess lesion significance at the time
of angiography and identify those who would most likely
benefit from revascularization. Although no clear consen-
sus exists on the degree of renal artery narrowing that
justifies revascularization, investigators generally define the
minimal threshold for an angiographically significant arte-
rial narrowing to be 50% luminal diameter reduction.3,4
This is acknowledged as only an approximate guide to the
hemodynamic effect of the stenosis.
Variables such a baseline mean blood pressure of110
mm Hg and bilateral RAS have previously been used to
predict improvement in blood pressure after RAR.8,9 Nei-
ther has been prospectively validated. One common in-
laboratory procedure is to measure translesional systolic
gradients, with a value of 20 mm Hg considered signifi-
cant and an indication for revascularization.3 This tech-
nique has not been standardized nor validated with regard
to clinical outcome after revascularization.4
The best-validated test that predicts clinical benefit
after revascularization is noninvasive RDUS-derived RI,
defined as [1 (EDV/PSV)]  100. The RI is considered
a useful measure of nephrosclerosis severity.
In a large single-center study, Radermacher et al5 eval-
uated the utility of RI in predicting outcome (hypertension
control, renal function, mortality) after elective revascular-
ization in RAS patients. Of the 5950 patients screened, 138
underwent renal arterial revascularization by angioplasty or
surgery. The 35 patients with an RI 80 experienced high
rate (80%) of decrease in renal function, without significant
improvement in hypertension control. In the 96 patients
with an RI 80, 94% had improvement in blood pressure
control, and only a small minority (3%) became dialysis-
dependent.5 Hence, the impact of revascularization on
patients with high RI values appears to be marginal.
The RI remains to date the only physiologic characteristic
that has been clinically validated as a predictor of out-
comes.4,6,10 Unfortunately, RI determination is typically per-
formed in a separate noninvasive laboratory and thus cannot
provide real-time data during endovascular procedures.
In RAIDER, we examined how well endovascular assess-
ment of renal RI correlated with the traditional noninvasive
technique. Noninvasive RIs were reported as an average of
two to fourmeasurements taken in the segmental artery and in
the distal, mid, and proximal portions of themain renal artery.
Invasive RI values similarly were reported as an average of
measurements taken in similar arterial locations.
Our primary findings were robust. There was an excel-
lent overall correlation between the two methods for RI
acquisition (r  0.86; 95% CI, 0.73 to 0.93; see Fig 2). The
correlation for RI values assessed by the two techniques on
each renal artery was also robust (r 0.92 for the right, r
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minutes per artery to perform the invasive RI assessment
was reasonable; this included operator and staff learning
curve for the device. We found the procedure to be safe,
with no major immediate complications in our study.
These findings are in agreement with recent data from
Slovut et al.11 In their pilot study, they reported a moderate
but significant correlation (r  0.63) between noninvasive
and endovascular measures of RI values in a cohort of 16
patients who were concomitantly undergoing renal flow re-
serve assessment.11 Previous investigators have also reported
Table II. Summary of study results*
Assessment Right
Renal resistive index
Doppler flow wire 78  20
Renal duplex ultrasound 78  21
Assessment r value 0.92
Renal span (cm)
Doppler flow wire 10.4  3.1
Renal duplex ultrasound 10.6  2.7
Assessment r value 0.44
Average renal PSV (cm/s)
Doppler flow wire 147  110
Renal duplex ultrasound 234  130
Assessment r value
Average renal EDV (cm/s)
Doppler flow wire 18.5  23.9
Renal duplex ultrasound 28.5  38.7
Assessment r value
Technical success (%) 100%
PSV, Peak systolic velocity; EDV, end-diastolic velocity.
*Data are presented as mean  standard deviation.
Fig 2. Scatter plot of renal index (RI) derived by catheter Dopp-
ler flow wire and renal duplex ultrasonography (RDUS). A robust
correlation is seen, with r  0.86 (95% CI, 0.73 to 0.93).similar use of endovascular flow wires to assess RI. Althoughthey did not compare it directly with RDUS, they found the
procedure to be relatively simple, rapid, and safe. 12,13
Pole-to-pole renal length is another important part of
the preintervention evaluation for RAS. A pole-to-pole
renal length of 7 to 8 cm is considered evidence of
significant renovascular disease and a predictor of poor re-
sponse after stenting. We studied how well assessing pole-to-
pole renal length by measuring contrast nephrograms during
angiography correlated with traditional RDUS. Our findings
suggested only a modest correlation (r 0.43; 95% CI, 0.11
to 0.67). A possible explanation for this result involves how
pole-to-pole renal length is measured. RDUS uses B-mode
ultrasound imaging to measure size and is often technically
difficult owing to obesity, patient movement, and excessive
bowel gas. In our study, 10% of kidneys could not be mea-
sured for size by RDUS.
Conversely, neither of these factors typically interferes
with pole-to-pole renal length assessment in the catheter-
ization lab. The only instance where we were unable to size
the kidney was when it did not appear on the imaging
screen owing to diameter limitations of the image intensi-
fier. This became less problematic during our recruitment
with the addition of a modern endovascular suite (Philips
Allura Xper FD 20) with a larger field of view. Overall, we
were able to measure pole-to-pole renal length by angiog-
raphy 97% of the time.
The present study also looked at the correlation be-
tween renal arterial PSV and EDV determined by both
techniques and a moderate but significant correlation was
found for both (r 0.66 and r 0.61, respectively). These
findings were not as robust as the RI findings, however.
Possible explanations for this likely relate to how veloc-
ities are derived with these two techniques. RDUS relies on
insonation of arteries at the point were the tightest lesions
exist, optimally with an insonation angle of 60°.14 The
Left Overall (95% CI)
82  21
81  20
0.79 0.86 (73-0.93)
10.9  2.9
11.0  2.8
0.37 0.43 (0.11-0.67)
127  102
185  110
0.66 (0.54-0.76)
13.3  12.3
19.3  18.9
0.61 (0.48-0.72)
100%Doppler wire emits an ultrasound beam that diverges at
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Despite being more apt to send signals at optimal angles,
this method may be affected by stenosis geometry, vessel
tortuosity, and intravascular velocity profile. Moreover, no
computer-assisted system is available that measures the
angle between the transducer and flow vector. Velocities
can also be affected by central hemodynamic conditions.
Thus changes in circulatory conditions (eg, cardiac output,
preload, afterload) potentially can change arterial velocities
between times of RDUS andDoppler flowwire assessment.
All of these could account for the moderate correlation
for PSV and EDV between the two methods. In fact, when
we re-examined our invasive PSV data, no correlation was
found with angiographic stenosis severity (r  0.03). RI
correlation, however, was strong in our study. This sug-
gests the proportional difference between PSV and EDV
are unchanged despite numerous factors that may affect
how actual velocities are measured using the Doppler wire.
A number of potential study limitations should be
mentioned:
First, endovascular Doppler assessment had not been com-
monly performed at our institution; hence, a period of
time was required to become facile with this procedure.
Second, there was an average interval of about 50 days be-
tween the time of RDUS and the time of endovascular
assessment. This time interval, as well as changes in dis-
ease state and hemodynamic conditions, may have con-
founded the data. However, based on our knowledge
that RAS is a disease that progresses over years (not
weeks),15-17 we believe that any effect on our findings
caused by the interval time would have been minimal.
Third, no effortsweremade towithhold drugs that could have
affected our investigation. Specifically, no systematic ef-
forts were made to stop angiotensin-converting enzyme
inhibitors or control for intraprocedural medications that
could have affected renal arterial flow conditions.
Four, postprocedure creatinine levels were not routinely
checked on all study patients. Thus, the safety profile in
terms of distal embolization and late renal failure re-
mains unknown.
CONCLUSION
RI values derived using an endovascular Doppler flow
wire strongly correlate with RI values derived from tradi-
tional RDUS. Measurements of pole-to-pole renal length
during angiography as well as assessing PSV also correlate
with RDUS measurements, but only to a moderate extent.
The procedure is safe, can be done in a reasonable time
frame, and provides immediate feedback to the operator.
Coupled with similar data in the existing literature, we
believe an appropriate anatomic and physiologic assessment
of renovascular disease can be performed during diagnostic
angiography by using these techniques.
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